Why can a coronary blockage be invisible at rest but appear during stress?

At rest a narrowed artery may still supply enough blood, but when exercise or a drug raises the heart's demand, the narrowed artery cannot increase supply enough, producing detectable ischemia in the ECG, wall motion, or perfusion.

When is pharmacologic stress used instead of exercise?

Pharmacologic stress is used when a person cannot exercise adequately; agents either increase demand or dilate the coronary bed to expose flow-limiting disease, paired with imaging to detect the resulting ischemia.

Stress Testing and Ischemia Detection

Stress testing provokes an increase in myocardial oxygen demand - by exercise or pharmacologic agents - to unmask a flow-limiting coronary stenosis that may be silent at rest. Inducible ischemia can be detected electrically on the ECG, by new wall-motion abnormalities on echocardiography, or by perfusion defects on nuclear imaging, and the test also gauges functional capacity.

Definition

Stress testing is the controlled provocation of increased myocardial workload, by exercise or pharmacologic stimulus, combined with electrical or imaging surveillance to detect ischemia produced by flow-limiting coronary disease and to assess functional capacity.

Scope

This topic covers the principles of cardiac stress testing and the detection of inducible ischemia: the physiological rationale of demand-supply mismatch, the exercise and pharmacologic methods of provoking it, and the electrical, echocardiographic, and nuclear means of detecting it. It is a reference topic and does not specify test selection or interpretation for an individual patient.

Core questions

How does provoking demand-supply mismatch reveal coronary disease that is silent at rest?
When is exercise stress preferred over pharmacologic stress, and what does each add?
How do ECG, echocardiographic, and nuclear methods differ in detecting inducible ischemia?

Key concepts

Myocardial oxygen demand-supply mismatch
Inducible ischemia
Exercise versus pharmacologic stress
Stress electrocardiography
Stress echocardiography
Functional capacity

Mechanisms

At rest, a coronary stenosis may not limit flow, but when exercise or a pharmacologic agent raises myocardial oxygen demand or maximally dilates the coronary bed, a stenosed artery cannot augment supply proportionally. The resulting ischemia manifests in a temporal cascade: perfusion heterogeneity appears first (detectable by nuclear imaging), then regional wall-motion abnormality (detectable by echocardiography), and then ST-segment changes on the ECG, often accompanied by symptoms. Exercise additionally yields functional capacity and the heart-rate and blood-pressure response, which carry prognostic value (Fletcher, 2013).

Clinical relevance

Stress testing is used to evaluate suspected stable coronary disease and to assess inducible ischemia and functional capacity, informing whether further anatomical evaluation is warranted (Knuuti, 2020; Fihn, 2012). The ISCHEMIA trial enrolled patients with moderate-to-severe inducible ischemia and is a key reference on how ischemia testing relates to management strategy (Maron, 2020). The entry describes the modality and is not a basis for individual diagnostic decisions.

Evidence & guidelines

Exercise testing methodology is standardised in the AHA exercise standards statement (Fletcher, 2013), and the role of ischemia testing in stable coronary disease is set out in ESC and ACCF/AHA guidelines (Knuuti, 2020; Fihn, 2012). The ISCHEMIA randomised trial provides outcome evidence in patients selected by inducible ischemia (Maron, 2020).

History

Exercise electrocardiography developed in the mid-twentieth century as a way to elicit ischemic ECG changes under graded exertion; imaging-based stress testing with echocardiography and radionuclide perfusion was later added to improve sensitivity and to localise ischemia, and pharmacologic stress extended testing to patients unable to exercise.

Debates

How much does revascularisation of inducible ischemia change outcomes?: Whether detecting and revascularising inducible ischemia in stable coronary disease improves hard outcomes beyond medical therapy was directly tested by the ISCHEMIA trial, which found no significant reduction in major events from an initial invasive strategy, reshaping how ischemia testing is interpreted.

Seminal works

fletcher-2013
maron-2020

Frequently asked questions

Why can a coronary blockage be invisible at rest but appear during stress?: At rest a narrowed artery may still supply enough blood, but when exercise or a drug raises the heart's demand, the narrowed artery cannot increase supply enough, producing detectable ischemia in the ECG, wall motion, or perfusion.
When is pharmacologic stress used instead of exercise?: Pharmacologic stress is used when a person cannot exercise adequately; agents either increase demand or dilate the coronary bed to expose flow-limiting disease, paired with imaging to detect the resulting ischemia.